
Xenetic Biosciences Investor Relations Material
Latest events

Status Update
Xenetic Biosciences
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Xenetic Biosciences Inc
Access all reports
Xenetic Biosciences, Inc. is a biotechnology company focused on developing immune-oncology therapies and drug delivery technologies. The company specializes in advancing novel treatments for cancer, leveraging its proprietary DNase-based platform designed to improve the effectiveness of chemotherapy and immunotherapy. The company is headquartered in Framingham, Massachusetts, and its shares are listed on the NASDAQ.
Key slides for Xenetic Biosciences Inc


Corporate Presentation
Xenetic Biosciences Inc


Corporate Presentation
Xenetic Biosciences Inc
Latest articles
)
Adobe: Equipping the Architects of Digital Expression
The story of how Adobe grew from a small garage upstart to one of the largest and most dominant software companies in the world.
21 Mar 2025
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
Ticker symbol
XBIO
Country
🇺🇸 United States